3.Preliminary results of supported chemotherapy in treatment of operated gastric cancer in Hai Phong (from January, 2001 to June, 2006)
Hoa Lam Nguyen ; Hung Quang Tran
Journal of Surgery 2007;57(1):49-55
Background: Gastric cancer is the second common disease among types of cancer, followed by lung cancer for male and breast cancer for female. The selection of appropriate regimens for illness and economic conditions of patients is always a difficult problem for clinicians. Objectives: To assess preliminary results of chemotherapy in treatment of gastric cancer in Hai Phong. Subjects and method: A longitudinal, cross-section study was conducted on 57 patients with gastric cancer (35 male, 21 female), treated in Viet Tiep hospital from January, 2002 to June, 2006. All of them were in stage of Dukes C, treated postoperative supported chemotherapy. Results: Side effects were common seen as vomit, nausea and diarrhea. They were often mild and disappeared after stopping medication. 30/57 patients responded to treatment. 21 patients were treated with regimen 5FU, however, amount of treatment cycles was very scattered and treatment effect was unclear. 36 patients were treated with multi-chemical regimens as FUFA, FAM and ELF. Their response to treatment was more clearly than regimen 5FU. During treatment, there were 6 patients who had not completely responded to treatment. In which, 4 patients developed more seriously: metastasis to liver, ovary, bone and lung. 2 patients had died. Conclusion: Regimen 5FU had a little toxicity. Regimen FUFA was more effective. The role of chemotherapy in supported treatment was unclear. Chemotherapy could be applied to patients with early stage of Dukes B.
Stomach Neoplasms/ therapy
;
Drug Therapy
;
4.The hematologic toxicity of MFC chemotherapy following surgery for gastric cancer.
Hyo Cheol PARK ; Jae Hong KIM ; Ju Sup PARK
Journal of the Korean Surgical Society 1992;42(2):171-178
No abstract available.
Drug Therapy*
;
Stomach Neoplasms*
5.Metabonomics-a useful tool for individualized cancer therapy.
Yanlan CHAI ; Juan WANG ; Zi LIU
Journal of Zhejiang University. Medical sciences 2013;42(6):705-710
Metabonomics has developed rapidly in post-genome era, and becomes a hot topic of omics. The core idea of metabonomics is to determine the metabolites of relatively low-weight molecular in organisms or cells, by a series of analytical methods such as nuclear magnetic resonance, color spectrum and mass spectrogram, then to transform the data of metabolic pattern into useful information, by chemometric tools and pattern recognition software, and to reveal the essence of life activities of the body. With advantages of high-throughput, high-sensitivity and high-accuracy, metabolomics shows great potential and value in cancer individualized treatment. This paper introduces the concept,contents and methods of metabonomics and reviews its application in cancer individualized therapy.
Humans
;
Metabolomics
;
Neoplasms
;
therapy
7.Recent advances in systemic chemotherapy for metastatic colorectal cancer.
Korean Journal of Medicine 2004;67(4):330-340
No abstract available.
Colorectal Neoplasms*
;
Drug Therapy*
8.Surgeon's View of Chemotherapy in Gastric Cancer.
Journal of the Korean Gastric Cancer Association 2003;3(4):166-171
No abstract available.
Drug Therapy*
;
Stomach Neoplasms*
9.Efficacy of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
The Korean Journal of Gastroenterology 2016;68(5):234-236
No abstract available.
Drug Therapy*
;
Stomach Neoplasms*
10.The prognostic value of serial measurement of serum CA-125 levels during chemotherapy of epithelial ovarian cancer.
Soon Beom KANG ; Hye Sung MOON ; Seung Kew BAIK ; Byung Gi KIM ; Yong Sang SONG ; Hyo Pyo LEE
Korean Journal of Obstetrics and Gynecology 1993;36(11):3750-3760
No abstract available.
Drug Therapy*
;
Ovarian Neoplasms*